24 valent pneumococcal conjugate vaccine for Pneumococcal Vaccines

"This study is not recruiting patients at the moment, however this could change in the future. According to clinicaltrials.gov, this trial was first posted on February 22nd, 2022 and was last edited on July 25th, 2022. There are 5 other similar trials that are currently looking for participants."

"This study is looking for 864 people, between the ages of 18 and 64 who have vaccines, pneumococcal. It is important that patients also meet the following criteria: Able and willing to complete the informed consent process., Available for clinical follow-up through the last study visit at 6 months after the study vaccination., Screening laboratory values must be within the central laboratory normal limits prior to study enrollment. Minor abnormalities are considered acceptable if not clinically significant., Able to provide proof of identity to the satisfaction of the study staff completing the enrollment process., Negative pregnancy test (urine and serum) for women of childbearing potential., Male"

"The ideal candidate for this clinical trial is someone who is under 64 years old and has already celebrated their 18th birthday."

"In addition to Precision Clinical Research in Sunrise, Florida, Acellacare of Wilmington in Wilmington, North carolina, and Benchmark Research in San Angelo, Texas; this study is also enrolling patients at 13 other sites."